Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Gossamer Bio, Inc. (GOSS)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gossamer Bio, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Gossamer Bio, Inc. since 2005.
The reporting company's ticker symbol is GOSS. The reporting company's CIK number is 1728117.
The total value of stock buying since 2005 is $626,122.
The total value of stock sales since 2005 is $10,300,920.
The total value of stock option exercises since 2005 is $449,755.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-12-30||Dupont Jakob (Chief Medical Officer)||Sale||40,000||15.00||600,000|
|2019-12-30||Dupont Jakob (Chief Medical Officer)||Option Ex||40,000||10.71||428,400|
|2019-12-27||Dupont Jakob (Chief Medical Officer)||Sale||1,994||15.81||31,535|
|2019-12-27||Dupont Jakob (Chief Medical Officer)||Option Ex||1,994||10.71||21,355|
|2019-09-27||Gujrathi Sheila (President & CEO)||Buy||10,000||16.80||167,979|
|2019-09-27||Christian Waage (EVP & General Counsel)||Buy||1,000||16.65||16,654|
|2019-09-27||Hasnain Faheem (Director)||Buy||10,000||16.80||167,979|
|2019-09-26||Giraudo Bryan (Chief Financial Officer)||Buy||1,121||16.78||18,810|
|2019-09-20||Omega Fund V Gp Manager, Ltd. (10% Owner)||Sale||183,607||21.96||4,032,560|
|2019-09-18||Stampacchia Otello (Other)||Sale||45,600||21.88||997,636|
|2019-09-17||Stampacchia Otello (Other)||Sale||23,400||21.61||505,790|
|2019-09-16||Stampacchia Otello (Other)||Sale||13,213||21.52||284,330|
|2019-09-11||Stampacchia Otello (Director)||Sale||80,403||21.31||1,713,629|
|2019-09-10||Stampacchia Otello (Director)||Sale||32,373||21.00||679,865|
|2019-09-06||Stampacchia Otello (Director)||Sale||8,700||21.51||187,102|
|2019-09-05||Stampacchia Otello (Director)||Sale||12,704||21.60||274,431|
|2019-08-29||Salter-cid Luisa (Chief Scientific Officer)||Sale||26,252||20.09||527,323|
|2019-08-28||Salter-cid Luisa (Chief Scientific Officer)||Sale||23,748||19.65||466,719|
|2019-05-30||Giraudo Bryan (Chief Financial Officer)||Buy||1,000||18.70||18,700|
|2019-02-12||Giraudo Bryan (Chief Financial Officer)||Buy||6,000||16.00||96,000|
|2019-02-12||Christian Waage (EVP & General Counsel)||Buy||1,550||16.00||24,800|
|2019-02-12||Cox Russell J. (Director)||Buy||7,200||16.00||115,200|
Insider trading activities including stock purchases, stock sales, and option exercises of GOSS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gossamer Bio, Inc. (symbol GOSS, CIK number 1728117) see the Securities and Exchange Commission (SEC) website.